Atlas Trials

Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Clinical trial NCT00073931 · COMPLETED

Trial details

NCT number
NCT00073931
Sponsor
Fred Hutchinson Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma
Start date
1999-10-01
Primary completion
2007-05-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.